UniQuest

UniQuest is the commercialisation company of The University of Queensland (UQ), established in 1984. In collaboration with UQ researchers, the company focuses on the commercialisation of UQ intellectual property (IP), thereby creating a significant impact. With a remarkable track record, UniQuest has led the research commercialisation in Australasia, establishing over 100 start-up companies based on UQ IP. Notable successes include the groundbreaking cervical cancer vaccine Gardasil® and the acquisitions of start-up companies Spinifex Pharmaceuticals Inc and Inflazome Ltd, marking two of the largest university start-up exits in Australian history.

UniQuest's success in bringing innovative technologies to market has positioned UQ as a leader in research commercialisation. The company's ability to translate intellectual property into successful ventures reflects its expertise. With its headquarters in Australia, UniQuest continues to drive impact through the commercialisation of UQ's IP, making significant contributions to the entrepreneurial ecosystem.